NRIX insider trading — Nurix Therapeutics, Inc.
Over the last 90 days, insiders at Nurix Therapeutics, Inc. (NRIX) made 0 open-market purchases worth $0 and 4 open-market sales worth $775K, making them net sellers by $775K. The largest sale was by Gregory Julia P (Director), who sold 22,583 shares for $529K on Oct 14, 2026.
Updated Oct 16, 2026.
Recent NRIX insider transactions
Every Form 4 filed by Nurix Therapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Hansen Gwenn | Chief Scientific Officer | M · Option exercise · 10b5-1 | Direct | 1,452 | $1.86 | $3K | Form 4 |
| Oct 15, 2026 | Hansen Gwenn | Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 1,452 | $25.00 | $36K | Form 4 |
| Oct 14, 2026 | Gregory Julia P | Director | M · Option exercise | Direct | 22,583 | $1.86 | $42K | Form 4 |
| Oct 14, 2026 | Gregory Julia P | Director | S · Sale | Direct | 22,583 | $23.40 | $529K | Form 4 |
| Oct 2, 2026 | Ring Christine | Chief Legal Officer | M · Option exercise · 10b5-1 | Direct | 5,786 | $8.72 | $50K | Form 4 |
| Oct 2, 2026 | Ring Christine | Chief Legal Officer | S · Sale · 10b5-1 | Direct | 5,786 | $23.19 | $134K | Form 4 |
| Sep 2, 2026 | Ring Christine | Chief Legal Officer | M · Option exercise · 10b5-1 | Direct | 5,787 | $8.72 | $50K | Form 4 |
| Sep 2, 2026 | Ring Christine | Chief Legal Officer | S · Sale · 10b5-1 | Direct | 5,787 | $25.76 | $149K | Form 4 |
| Sep 1, 2026 | Hansen Gwenn | Chief Scientific Officer | M · Option exercise · 10b5-1 | Direct | 1,452 | $1.86 | $3K | Form 4 |
| Sep 1, 2026 | Hansen Gwenn | Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 1,452 | $25.47 | $37K | Form 4 |
| Aug 5, 2026 | Hansen Gwenn | Chief Scientific Officer | M · Option exercise · 10b5-1 | Direct | 4,356 | $1.86 | $8K | Form 4 |
| Aug 5, 2026 | Hansen Gwenn | Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 4,356 | $25.00 | $109K | Form 4 |
| Aug 4, 2026 | Hansen Gwenn | Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 4,111 | $24.36 | $100K | Form 4 |
| Aug 4, 2026 | Van Houte Hans | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 4,761 | $24.36 | $116K | Form 4 |
| Aug 3, 2026 | Ring Christine | Chief Legal Officer | M · Option exercise · 10b5-1 | Direct | 5,787 | $8.72 | $50K | Form 4 |
| Aug 3, 2026 | Ring Christine | Chief Legal Officer | S · Sale · 10b5-1 | Direct | 16,589 | $23.05 | $382K | Form 4 |
| Jul 30, 2026 | Van Houte Hans | Chief Financial Officer | M · Option exercise | Direct | 10,180 | — | — | Form 4 |
| Jul 30, 2026 | Van Houte Hans | Chief Financial Officer | S · Sale | Direct | 2,845 | $23.38 | $67K | Form 4 |
| Jul 30, 2026 | Ring Christine | Chief Legal Officer | M · Option exercise | Direct | 10,180 | — | — | Form 4 |
| Jul 30, 2026 | Ring Christine | Chief Legal Officer | S · Sale | Direct | 3,847 | $23.38 | $90K | Form 4 |
| Jul 30, 2026 | Hansen Gwenn | Chief Scientific Officer | M · Option exercise | Direct | 10,180 | — | — | Form 4 |
| Jul 30, 2026 | Hansen Gwenn | Chief Scientific Officer | S · Sale | Direct | 3,847 | $23.38 | $90K | Form 4 |
NRIX insider trading FAQ
Are insiders buying NRIX stock?
Not on the open market. In the last 90 days, Nurix Therapeutics, Inc. insiders made no open-market purchases, and 4 open-market sales totaling $775K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading NRIX?
Recent sellers: Gregory Julia P, Hansen Gwenn, Ring Christine, Van Houte Hans.
Where does NRIX insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.